A FHIR Human Leukocyte Antigen (HLA) Interface for Platelet Transfusion Support
- 1 April 2017
- journal article
- Published by Georg Thieme Verlag KG in Applied Clinical Informatics
- Vol. 08 (02) , 603-611
Abstract
Summary: Platelet transfusions are a cornerstone of therapy for patients who develop thrombocytopenia while undergoing Hematopoietic Stem Cell Transplantation (HSCT). Many patients who develop Platelet Transfusion Refractoriness (PTR) require HLA-matched platelets. Identifying these patients early could lead to better utilization of platelets as well as increased platelet counts. We built a SMART on FHIR visualization tool to aid the oncology, blood bank, and blood donor center teams in identifying these patients by showing trends in thrombocytopenia along with a computer generated calculated Panel Reactive Antibody (cPRA) level. To do this, we required a FHIR interface to our HLA database. We describe our methods and outcome for constructing this FHIR interface, as well as the architecture and data flow of HLA data from its proprietary database to the SMART on FHIR environment and application database along with RESTful cPRA web service calculator. Future work will evaluate the clinical impact of this platelet visualization tool and overall success of our FHIR implementation. Citation: Gordon WJ, Baronas J, Lane WJ. A FHIR human leukocyte antigen (HLA) interface for platelet transfusion Support. Appl Clin Inform 2017; 8: 603–611 https://doi.org/10.4338/ACI-2017-01-CR-0010Keywords
This publication has 15 references indexed in Scilit:
- SMART on FHIR: a standards-based, interoperable apps platform for electronic health recordsJournal of the American Medical Informatics Association, 2016
- Histoimmunogenetics Markup Language 1.0: Reporting next generation sequencing-based HLA and KIR genotypingHuman Immunology, 2015
- Platelet Transfusion: A Clinical Practice Guideline From the AABBAnnals of Internal Medicine, 2015
- Using lean techniques to define the platelet (PLT) transfusion process and cost‐effectiveness to evaluate PLT dose transfusion strategiesTransfusion, 2012
- A comprehensive program to minimize platelet outdatingTransfusion, 2011
- Hematopoietic Stem Cell TransplantationA Global PerspectiveJAMA, 2010
- Platelet transfusion refractorinessBritish Journal of Haematology, 2008
- Reactions Induced by Platelet TransfusionsTransfusion Medicine and Hemotherapy, 2008
- The HLA System: Genetics, Immunology, Clinical Testing, and Clinical ImplicationsYonsei Medical Journal, 2007
- Leukocyte Reduction and Ultraviolet B Irradiation of Platelets to Prevent Alloimmunization and Refractoriness to Platelet TransfusionsNew England Journal of Medicine, 1997